GlassScriptPhysician profile
Richard J Rode
NPI 1467469437
$591.00
in general payments reported to CMS, 2019-2025
10 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $13.94 · 2023: $99.45 · 2024: $231 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $473.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $248.01 | 2023-2025 | Preveleak, Tachosil, Floseal |
| Abbott Laboratories | $101.53 | 2024 | Mitraclip |
| Atricure, INC. | $47.21 | 2021 | |
| Chiesi USA, INC. | $36.64 | 2023-2025 | Cleviprex, Kengreal |
| W. L. Gore & Associates, INC. | $31.10 | 2023 | Gore Tag Conformable Thoracic Endoprosthesis |
| La Jolla Pharmaceutical Company | $29.92 | 2025 | Giapreza |
| Haemonetics Corporation | $28.44 | 2021 | |
| Davol INC. | $28.16 | 2021 | |
| Kls-Martin L.P. | $26.05 | 2024 | |
| Medtronic, INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Rode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.